Anaphylaxis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Anaphylaxis Pipeline Drugs Market Overview

Anaphylaxis is a severe, potentially life-threatening allergic reaction. Anaphylaxis symptoms include dizziness, nausea, vomiting or diarrhea, feeling of warmth, constriction of the airways and a swollen tongue or throat. Risk factors include personal history of anaphylaxis, allergies or asthma and family history. Treatment includes beta-agonist, antihistamines and cortisone.

The Anaphylaxis pipeline drugs market research report provides a comprehensive information on the therapeutics under development for Anaphylaxis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Anaphylaxis and features dormant and discontinued projects.

For more insights on Anaphylaxis pipeline drugs market, download a free report sample

Anaphylaxis Pipeline Drugs Market Segmentation by Targets

The key targets in the Anaphylaxis pipeline drugs market are Alpha 1 Adrenergic Receptor, Alpha 2 Adrenergic Receptor, Beta 1 Adrenergic Receptor, Beta 2 Adrenergic Receptor, Alpha Adrenergic Receptor, Beta Adrenergic Receptor, Beta 3 Adrenergic Receptor, High Affinity Immunoglobulin Gamma Fc Receptor I, and Low Affinity Immunoglobulin Gamma Fc Region Receptor II-a among others.

Anaphylaxis Pipeline Drugs Market Analysis, by Targets

For more insights on Anaphylaxis pipeline drugs targets, download a free report sample

Anaphylaxis Pipeline Drugs Market Segmentation by Key Mechanism of Actions

The key mechanism of actions in the Anaphylaxis pipeline drugs market are Alpha 1 Adrenergic Receptor Agonist, Alpha 2 Adrenergic Receptor Agonist, Beta 1 Adrenergic Receptor Agonist, Beta 2 Adrenergic Receptor Agonist, Alpha Adrenergic Receptor Agonist, Beta Adrenergic Receptor Agonist, and Beta 3 Adrenergic Receptor Agonist among others.

Anaphylaxis Pipeline Drugs Market Analysis, by Mechanism of Actions

For more insights on Anaphylaxis pipeline drugs mechanism of actions, download a free report sample

Anaphylaxis Pipeline Drugs Market Segmentation by Key Routes of Administration

The key routes of administration in the Anaphylaxis pipeline drugs market are nasal, sublingual, buccal, inhalational, intramuscular, and oral.

Anaphylaxis Pipeline Drugs Market Analysis, by Routes of Administration

For more insights on Anaphylaxis pipeline drugs routes of administration, download a free report sample

Anaphylaxis Pipeline Drugs Market Segmentation by Molecule Types

The key molecule types in the Anaphylaxis pipeline drugs market are small molecule, monoclonal antibody, and antisense oligonucleotide.

Anaphylaxis Pipeline Drugs Market Analysis, by Molecule Types

For more insights on Anaphylaxis pipeline drugs molecule type, download a free report sample

Competitive Landscape

Some of the leading companies in the Anaphylaxis pipeline drugs market are Aquestive Therapeutics Inc, ARS Pharmaceuticals Inc, Allakos Inc, BioArdis LLC, Bryn Pharma LLC, Crossject SA, Hoth Therapeutics Inc, Klaria Pharma Holding AB, and Nasus Pharma Ltd among others.

Aquestive Therapeutics Inc: Aquestive Therapeutics Inc (Aquestive) discovers, develops and commercializes prescription drug products. The company’s product portfolio includes sympazan, a film formulation of clobazamor for treating seizures associated with Lennox-Gastaut syndrome (LGS); suboxone for the treatment of opioid dependence; zuplenz for the treatment of nausea and  vomiting; and diazepam. It also provides nutraceuticals, packaging solutions, and consumer products. Aquestive provides PharmFilm, a drug delivery platform that delivers existing prescription products directly to the bloodstream. The company collaborates with other pharmaceutical companies for the development and commercialization of its pharmaceutical products. The company has manufacturing facility in Indiana, the US. Aquestive Therapeutics is headquartered in Warren, New Jersey, the US.

Anaphylaxis Pipeline Drugs Market Analysis, by Companies

To know more about the leading players in the Anaphylaxis pipeline drugs market, download a free report sample

Scope

• The pipeline guide provides a snapshot of the global therapeutic landscape of Anaphylaxis (Immunology).
• The pipeline guide reviews pipeline therapeutics for Anaphylaxis (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Anaphylaxis (Immunology) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Anaphylaxis (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Anaphylaxis (Immunology)

Reasons to Buy

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Anaphylaxis (Immunology).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Anaphylaxis (Immunology) pipeline depth and focus of Indication therapeutics.

• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.